- Home
- FTHA vs MIST Comparison
FTHA vs MIST Comparison
Compare FTHA & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$1.13
Company Overview
Basic Information| Metric | FTHA | MIST |
|---|---|---|
| Founded | N/A | 2003 |
| Country | Cayman Islands | Canada |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.6M | 146.9M |
| IPO Year | 2026 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FTHA | MIST |
|---|---|---|
| Price | $9.97 | $1.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 5.0K | ★ 1.7M |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $1.00 |
| 52 Week High | $9.97 | $3.06 |
Technical Indicators
Market Signals| Indicator | FTHA | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 68.26 | 47.88 |
| Support Level | $9.93 | $1.01 |
| Resistance Level | N/A | $1.42 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 100.00 | 49.62 |
Price Performance
Historical Comparison FTHA
MIST
About FTHA Forefront Tech Holdings Acquisition Corp Class A Ordinary Shares
Forefront Tech Holdings Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.